San Diego's Autobahn Therapeutics raises $32.7 million to pursue depression treatment
Startup plans to launch early stage dosing trial for its mental health therapy later this year.
Source: sandiegouniontribune.com
Stay updated with breaking news from Pfizer Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Startup plans to launch early stage dosing trial for its mental health therapy later this year.
Industry veteran to lead STORM as it transitions into a clinical-stage company with a pipeline of products targeting RNA modifying enzymes Dr. McMahon Joins as Board Director CAMBRIDGE
/PRNewswire/ -- Anjarium Biosciences AG ("Anjarium"), a biotech company focused on creating and delivering a new class of non-viral gene therapies, today...
Biomedical grantmakers’ DEI push gains new momentum